Management of severe anogenital acne inversa (Hidradenitis Suppurativa)

Dermatologic Surgery

Volumn 38, Issue 1, 2012, Pages 110-117

  Wollina, Uwe ^a   Tilp, Michaela ^a   Meseg, Antje ^a   Schönlebe, Jaqueline ^a   Heinig, Birgit ^a   Nowak, Andreas ^a  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SUPPURATIVE HIDRADENITIS; TREATMENT OUTCOME;

ADULT; AGED; ANAL CANAL; FEMALE; GENITALIA; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84855560967     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.02157.x     Document Type: Article

References (30)

1. Danby FW, Margesson LJ. Hidradenitis suppurativa. Dermatol Clin 2010;28:779-93.
2. Sartorius K, Emtestam L, Jenec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009;161:831-9.
3. Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009;61:51-7.
4. Schweiger ES, Riddle CC, Aires DJ. Treatment of hidradenitis suppurative by photodynamic therapy with aminolevulinic acid: preliminary results. J Drugs Dermatol 2011;10:381-6.
5. von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol 2011;164:367-71.
6. Hunger RE, Surovy AM, Hassan AS, Braathen LR, et al. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol 2008;158:691-7. (Pubitemid 351415729)
7. Wolk K, Warszawska K, Hoeflich C, Witte E, et al. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol 2011;186:1228-39.
8. Wang B, Yang W, Wen W, Sun J, et al. Gamma-secretase gene mutations in familial acne inversa. Science 2010;330:1065.
9. Marquardt AL, Hackshaw KV. Reactive arthritis associated with hidradenitis suppurativa. J Natl Med Assoc 2009;101:367-9.
10. Faye O, Petit F, Poli F, Petit T, et al. [Lymphedema as a complication of hidradenitis suppurativa in three patients]. Ann Dermatol Venereol 2007;134:567-9.
11. Lavogiez C, Delaporte E, Darras-Vercambre S, De Lassalle E, et al. Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology 2010;220:147-53.
12. Bieniek A, Matusiak L, Okulewicz-Gojlik D, Szepietowski JC. Surgical treatment of hidradenitis suppurativa: experiences and recommendations. Dermatol Surg 2010;36:1998-2004.
13. Menderes A, Sunay O, Vayvada H, Yilmaz M. Surgical management of hidradenitis suppurativa. Int J Med Sci 2010;7(4):240-7.
14. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus surgical approach. In: Roenigk RK, Roenigk HH, editors. Dermatologic surgery, New York: Marcel Dekker; 1989; pp. 729-39.
15. Balik E, Eren T, Bulut T, Büyükuncu Y, et al. Surgical approach to extensive hidradenitis suppurativa in the perineal/perianal and gluteal regions. World J Surg 2009;33:481-7.
16. Bocchini SF, Habr-Gama A, Kiss DR, Imperiale AR, et al. Gluteal and perianal hidradenitis suppurativa: surgical treatment by wide excision. Dis Colon Rectum 2003;46:944-9. (Pubitemid 36875492)
17. Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg 2000;26:638-43. (Pubitemid 30470626)
18. Wollina U, Heinig B, Uhlemann C. Transdermal CO2 application in chronic wounds. Int J Low Extrem Wounds 2004;3:103-6.
19. Rieger UM, Erba P, Pierer G, Kalbermatten DF. Hidradenitis suppurativa of the groin treated by radical excision and defect closure by medial thigh lift: aesthetic surgery meets reconstructive surgery. J Plast Reconstr Aesthet Surg 2009;62:1355-60.
20. Kishi K, Nakajima H, Imanishi N. Reconstruction of skin defects after resection of severe gluteal hidradenitis suppurativa with fasciocutaneous flaps. J Plast Reconstr Aesthet Surg 2009;62:800-5.
21. Kishi K, Nakajima H, Imanishi N, Nakajima T. Extended split superior gluteus maximus musculocutaneous flap and reconstruction after resection of perianal and lower gluteal hidradenitis suppurativa. J Plast Reconstr Aesthet Surg 2009;62:1081-6.
22. Harrison BJ, Mudge E, Hughes LE. Recurrence after surgical treatment of hidradenitis suppurativa. BMJ 1987;294:487-9. (Pubitemid 17020466)
23. Kurzen H, Schönfelder-Funcke S, Hartschuh W. Surgical treatment of acne inversa at the university of Heidelberg. Coloproctology 2000;22:76-80. (Pubitemid 30349322)
24. Matusiak L, Bieniek A, Szepietowski JC. Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents? Acta Derm Venereol 2009;89:601-3.
25. Amano M, Grant A, Kerdel FA. A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa. Int J Dermatol 2010;49:950-5.
26. Miller I, Lynggaard CD, Lophaven S, Zachariae C, et al. A double blind placebo controlled randomised trial of adalimumab in the treatment of hidradenitis suppurativa. Br J Dermatol 2011; doi: 1111/j.1365-2133.2011.10338. x.
27. Adams DR, Yankura JA, Fogelberg AC, Anderson BE. Treatment of hidradenitis suppurativa with etanercept injection. Arch Dermatol 2010;146:501-4.
28. Brunasso AM, Massone C. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: an update on infliximab. Acta Derm Venereol 2011;91:70-1.
29. Grant A, Gonzalez T, Montgomery MO, Cardenas V, et al. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol 2010;62:205-17.
30. Lasocki A, Sinclair R, Foley P, Saunders H. Hidradenitis suppurativa responding to treatment with infliximab. Australas J Dermatol 2010;51:186-90.